BioMérieux
Top 10 Articles on 360Dx in 2022
In 2022 readers were most interested in a story about what happened to Cepheid's GeneXpert Omni, a point-of-care platform once touted by the company.
BioMérieux Gets CE Mark for Next-Gen Immunoassay System
The system runs the company's line of Vidas tests for emergency and critical care, immunochemistry, infectious diseases, and food industry pathogens.
Roche, BioMérieux, Abbott Gain FDA 510(k) Clearances in October
The month's clearances included tests for COVID-19, antimicrobial resistance, sexually transmitted infections, fever-causing infections, and blood glucose levels.
BioMérieux Q3 Revenues up 3 Percent
The Marcy l’Étoile, France-based firm said sales of its non-respiratory syndromic molecular panels increased 30 percent in the quarter.
BioMérieux, BrightInsight Partner for Clinical Decision Support Solution
The partners will develop a regulated global tool to support clinical decision-making after diagnostic testing.
May 13, 2022
BioMérieux Gets CE Mark for Vidas Chikungunya Assays
Apr 11, 2022